Noninvasive spinal cord stimulation to help glucose control in adults with and without spinal cord injury
Official title: Effects of Noninvasive Spinal Cord Neuromodulation on Metabolic Function
Run by University of Kentucky · NCT07597161 · Data updated 2026-11-12
This study tests whether noninvasive transcutaneous spinal cord stimulation can improve glucose regulation in adults with normal, prediabetic, or type 2 diabetic glucose levels, including people with spinal cord injury.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Kentucky Academic / other |
| Locations | 1 site (Lexington, Kentucky) |
| Status | Recruiting |
| Started | October 20, 2026 |
| Main results expected | May 31, 2030 |
| Study ends | December 2030 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07597161 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with chronic spinal cord injury (T6 or above or AIS A-D) or able-bodied, and with normal glucose metabolism, prediabetes, or type 2 diabetes.
✕Probably not a fit
Individuals with conditions or circumstances that preclude safe tSCS or that do not respond to neuromodulation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study will evaluate the acute and chronic effects of transcutaneous spinal cord stimulation (tSCS) on glucose metabolism in adults with and without spinal cord injury. Participants will receive active tSCS or sham stimulation to assess changes in glucose and insulin responses during an oral glucose tolerance test, as well as longer-term measures such as HbA1c, insulin sensitivity, and metabolic biomarkers. The trial aims to determine feasibility, safety, and potential metabolic benefits across a spectrum of metabolic states. Primary outcomes focus on glucose and insulin responses, while secondary outcomes explore broader metabolic changes. The study is conducted at a single site in Lexington, Kentucky, led by a researcher team with no listed collaborators.
Why it matters
Potential benefit: If successful, participants could experience improved glucose regulation and metabolic health, potentially reducing diabetes risk or progression.
How similar studies have gone: Recent neuromodulation efforts targeting metabolic function have shown promising signals, but this specific noninvasive tSCS approach remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be at least 18 years of age and able to provide informed consent. * Chronic spinal cord injury (at least 1 year post-injury) with neurological level of injury T6 or above, classified as AIS A-D, or able-bodied individuals without a history of spinal cord injury or neurological disorder * Participants must meet criteria for normal glucose metabolism, prediabetes, or type 2 diabetes, determined using HbA1c, fasting plasma glucose, fasting insulin, or oral glucose tolerance testing (OGTT). Normal glucose metabolism is defined as HbA1c less than 5.7% and fasting plasma glucose less than or equal to 100 mg/dL. Impaired glucose metabolism (prediabetes or type 2 diabetes) will be identified by HbA1c greater than or equal to 5.7%, fasting plasma glucose greater than100 mg/dL (5.6 mmol/L), fasting insulin greater than 8.5-10 µIU/mL after at least 8 hours of fasting, or 2-hour plasma glucose greater than 140 mg/dL (7.8 mmol/L) during a standard OGTT performed using a 75 g anhydrous glucose load dissolved in water. * Participants taking diabetes medications may be included if their medication regimen has been stable for at least 12 weeks before enrollment. This ensures observed metabolic changes are attributable to tSCS rather than recent medication adjustments. Medication use will be documented and included as a covariate in analyses to account for potential effects Exclusion Criteria: * Unstable medical conditions (e.g., cardiac disease, active infections). * Implanted devices (e.g., pacemakers, neurostimulators, ITB pumps). * Change of medications that alter glucose metabolism (e.g., corticosteroids). * Frequent, symptomatic hypoglycemia. * Inability to tolerate stimulation procedures or complete study protocols. * Diagnosis of Type 1 diabetes mellitus. * Skin breakdown, eczema, or other dermatological conditions (e.g., psoriasis) affecting the skin at the site of electrodes placement. * Females who are pregnant, breastfeeding, or intend to become pregnant. * Cognitive impairments, social/psychological problems, or other comorbid conditions that, in the opinion of the Investigator, will preclude them from participation.
Where it's running
-
Department of Physical Medicine and Rehabilitation-Research Suite
Lexington, Kentucky, United States Recruiting
Study contacts
- Study coordinator: Rahul Sachedva, PhD
- Email: rsa327@uky.edu
- Phone: 859-257-4888
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rehabilitation data registry for spinal cord injury in Korea
This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury
This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.
-
Able Kids device: safer gait aid for kids with neurologic gait problems
This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.
-
Dose optimization of acute intermittent hypoxia for improving leg strength after spinal cord injury
This study tests different short bursts of low-oxygen exposure to see which dose helps people with spinal cord injuries gain stronger leg muscles and faster reactions.
-
AI-guided prediction of blood pressure changes in spinal cord injury using perfusion index during a cool-temperature test
This study tests whether perfusion index can reliably predict changes in systolic blood pressure in people with spinal cord injury during a controlled cool temperature challenge.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.